Texas Oncology has selected proXimity™ as the primary tool to automate the transfer of clinical trial data from the oncology EMR to the electronic data capture (EDC) systems used by biotech, pharmaceutical, and contract research organizations providing clinical trials with Texas Oncology.
proXimity is an innovative cloud-based software platform that accelerates the transfer of clinical trial subject data from multiple electronic medical records (EMR) to the sponsor’s electronic data capture systems (EDC). Typically, this data is transcribed manually by data management employees from the EMR to the EDC, which is time-intensive and error-prone. proXimity automates this process and transfers the data from one system to another without the need for manual transcription, dramatically reducing the time needed to transfer data while eliminating transcription errors.
Texas Oncology is a leader in cancer research and clinical trials with more than 1500 patients enrolled annually and, on average, 150+ open national trials. In a recent pilot study conducted using proXimity to transfer data from the EMR to the EDC, the data transfer using proXimity™ was 4.5 times faster than manual entry and the data was transferred error free compared to manual entry.
“We look forward to leveraging proXimity in our ongoing program to combine clinical and operational excellence in the performance of clinical trials. With our large network and mass of data, proXimity holds the potential to not only accelerate data entry and management, but also to significantly improve its accuracy. This is a big win for cancer research and cancer patients in Texas,”
Scott Paulson, M.D. medical oncologist and director of clinical research at Texas Oncology
